Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis and genetics of psoriasis

A Menter1

  • 1Division of Dermatology, Baylor University Medical Center, Dallas, Texas, USA.

Cutis
|October 27, 1998
PubMed
Summary

Psoriasis is a systemic autoimmune disease with genetic and T cell-driven causes. Understanding its genetic basis is key to developing targeted therapies and potential gene treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomized phase III trial (AMAGINE-1).

The British journal of dermatology·2020
Same author

Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study.

The British journal of dermatology·2020
Same author

Defining drug-free remission of skin disease in patients with plaque psoriasis.

The British journal of dermatology·2019
Same author

Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Area of Science:

  • Immunology
  • Genetics
  • Dermatology

Background:

  • Psoriasis is increasingly recognized as a systemic autoimmune disease, not just a skin condition.
  • Its pathogenesis involves genetic predisposition and T cell-mediated immune responses.
  • Environmental factors also play a role alongside genetic susceptibility.

Purpose of the Study:

  • To highlight the advancements in understanding psoriasis pathogenesis.
  • To emphasize the genetic and autoimmune components of the disease.
  • To discuss the implications for future psoriasis treatments.

Main Methods:

  • Review of population, family, and twin studies.
  • Analysis of genetic-linkage studies identifying multiple genetic loci.
  • Examination of immunological findings, such as activated T cells in lesions.

Main Results:

  • Strong evidence for a significant genetic component in psoriasis development.
  • Identification of multiple genetic loci associated with psoriasis.
  • Confirmation of T cell-dependent autoimmune mechanisms in disease pathogenesis.

Conclusions:

  • Psoriasis is a complex, hereditary autoimmune disease with systemic effects.
  • Further unraveling the genetic basis will lead to improved, targeted therapies.
  • Gene therapy presents a promising future treatment avenue for psoriasis.

Related Experiment Videos